Related Experiment Video

Updated: Dec 15, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K

The Multifaced Perspectives of Genetic Testing in Pediatric Cardiomyopathies and Channelopathies

Nicoleta-Monica Popa-Fotea1,2, Cosmin Cojocaru1, Alexandru Scafa-Udriste1,2

  • 1Department of Cardiology, Clinical Emergency Hospital of Bucharest, Floreasca Street 8, 014461 Bucharest, Romania.

Journal of Clinical Medicine
|July 9, 2020
PubMed

Insights

Diagnosing pediatric cardiomyopathies (CMPs) and channelopathies (CNPs) often requires genetic testing. This review synthesizes guidelines and psychosocial factors for comprehensive genetic assessment in children.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Pediatric cardiomyopathies (CMPs) and channelopathies (CNPs) are significant causes of mortality in children.
  • Conventional diagnostic methods often fall short, necessitating advanced testing for timely intervention.
  • Genetic testing offers insights into the underlying causes of these complex pediatric heart conditions.

Purpose of the Study:

  • To provide a comprehensive genetic assessment framework for pediatric CMPs and CNPs.
  • To integrate current European and American guideline recommendations for genetic evaluation.
  • To address the unique challenges and psychosocial aspects of genetic diagnosis in pediatric heart diseases.

Main Methods:

  • Literature review synthesizing current guidelines from European and American bodies.
  • Analysis of the diverse etiologies and limited randomized studies in pediatric CMPs and CNPs.
  • Inclusion of psychosocial perspectives in the genetic assessment strategy.

Main Results:

  • Genetic testing is crucial but requires careful consideration due to varied guidelines and limited evidence.
  • The complexity of pediatric CMPs and CNPs necessitates a cautious approach to genetic testing.
  • Integrating psychosocial factors is essential for a holistic genetic diagnosis.

Conclusions:

  • A comprehensive genetic assessment, incorporating guidelines and psychosocial factors, is vital for pediatric CMPs and CNPs.
  • Standardized recommendations for genetic evaluation timing and methodology are needed.
  • Addressing the psychological impact is key to effective genetic diagnosis and management in pediatric heart conditions.

Keywords:
cardiomyopathieschannelopathiesgenetic testingpediatricspsychological impact

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.0K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.5K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
249
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
369
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
308
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
203
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
326
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
131